Medicare Enrolled

Dr. Tailun Zhao, M.D.

Ophthalmology · El Cajon, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
450 FLETCHER PKWY STE 112, El Cajon, CA 92020
8008982020
In practice since 2012 (13 years)
NPI: 1952659203 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zhao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zhao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zhao

Dr. Tailun Zhao is an ophthalmology specialist in El Cajon, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Zhao performed 15,918 Medicare services across 1,890 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zhao received a total of $2,404 from 22 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zhao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 7% volume in CA $2,404 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,918
Medicare services
Top 7% in CA for ophthalmology
1,890
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,224 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
7,560 $29 $42
Injection, ranibizumab, 0.1 mg 3,091 $187 $501
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,654 $28 $99
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,226 $91 $1,283
Aflibercept eye injection (Eylea) 1,056 $696 $1,250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
671 $60 $174
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
228 $86 $301
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
224 $70 $111
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
63 $100 $244
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
36 $102 $277
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
32 $69 $182
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $113 $238
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
18 $111 $335
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $28 $75
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
13 $32 $82
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,404
Total received (2018-2024)
Avg $343/year across 7 years
Top 39% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,404 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$650
2023
$416
2022
$626
2021
$344
2020
$213
2019
$20
2018
$136

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$201
Alcon Vision LLC
$135
Amgen Inc.
$132
Tarsus Pharmaceuticals, Inc.
$55
Bausch & Lomb Americas Inc.
$51
ABBVIE INC.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Biogen, Inc.
$17
Top 3 companies account for 71.9% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$570
Novartis Pharmaceuticals Corporation
$340
Glaukos Corporation
$201
Alcon Vision LLC
$187
Bausch & Lomb Americas Inc.
$134
Amgen Inc.
$132
Genentech USA, Inc.
$131
ABBVIE INC.
$116
Sun Pharmaceutical Industries Inc.
$114
Biogen, Inc.
$82
SUN PHARMACEUTICAL INDUSTRIES INC.
$82
Astellas Pharma US Inc
$60
Tarsus Pharmaceuticals, Inc.
$55
Aerie Pharmaceuticals, Inc.
$36
Coherus Biosciences Inc.
$31
Genentech, Inc.
$27
AbbVie Inc.
$23
Kala Pharmaceuticals, Inc.
$19
Bausch & Lomb, a division of Bausch Health US, LLC
$19
Apellis Pharmaceuticals, Inc.
$18
Horizon Therapeutics plc
$14
Oyster Point Pharma, Inc.
$13
Top 3 companies account for 46.2% of all-time payments
Associated products mentioned in payments ›
BEOVU · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · Cequa · Cimerli · EYLEA · EYLEA HD · INVELTYS · LOTEMAX SM · LUMIGAN · Lucentis · MIEBO · NGENUITY · OZURDEX · RETISERT · Syfovre · TEPEZZA · TYRVAYA · VABYSMO · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · XIPERE · enVista MX60 IOL · iDose · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in El Cajon?
Compare ophthalmologists in the El Cajon area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
280
Per 100K population
8.5
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zhao is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zhao experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Zhao performed 7,560 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zhao receive payments from pharmaceutical companies?
Yes. Dr. Zhao received a total of $2,404 from 22 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zhao's costs compare to other ophthalmologists in El Cajon?
Dr. Zhao's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zhao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →